An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
Christopher W. Woods, Ana M. Sanchez, Geeta K. Swamy, Micah T. McClain, Lynn Harrington, Debra Freeman, Elizabeth A. Poore, Dawn K. Slifka, Danae E. Poer DeRaad, Ian J. Amanna, Mark K. Slifka, Shu Cai, Venus Shahamatdar, Michael R. Wierzbicki, Cyrille Amegashie, Emmanuel B. Walter
Dive into the research topics of 'An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults'. Together they form a unique fingerprint.